Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- The Sovereign Architects of India’s Digital Century: Top 50 Women IT Leaders
- PoK Gamble: Rhetoric Meets Realpolitik Along the Line of Control
- 4.3 Crore Indians Stranded in Unemployment as Youth Crisis Deepens – Network 7 Research Findings
- Rebuilding Trust: Nandan Nilekani Named Head of High-Powered Task Force to Overhaul India’s Examination System
- The Tectonic Shift: How Student Power Shattered New Delhi’s Doctrine of Absolute Immunity










